Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose versus low-dose domperidone for lactation insufficiency in mothers of preterm infants
ACTRN12621000508875Phase 3Recruiting
- Sponsor
- South Australian Health and Medical Research Institute
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of domperidone in hypogalactia, sponsored by South Australian Health and Medical Research Institute. Started Sep 2022; status: recruiting.
02
Drugs
domperidone
03
Conditions
hypogalactia
Beyond the preview
Go deeper on ACTRN12621000508875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000508875.